News
67. Chi KN, Rathkopf DE, Smith MR, et al: Phase 3 MAGNITUDE study: First results of niraparib (NIRA) with abiraterone acetate and prednisone (AAP) as first-line therapy in patients (pts) with ...
The race to become New York City’s next mayor and its candidates.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback